title: Prevention of omalizumab-induced headache.
authors.affiliation: Principal Clinical Advice Pharmacist, Southampton Medicines Advice Service, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
authors.forename: Jonathan
authors.initials: J
authors.lastname: Hall
authors.affiliation: Head of Paediatric Respiratory Department, Southampton Children's Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
authors.forename: Julian
authors.initials: J
authors.lastname: Legg
mesh_terms: D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002648:Child; D005260:Female; D006261:Headache / Q000139:chemically induced* / Q000517:prevention & control*; D006801:Humans; D000069444:Omalizumab / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D018927:Anti-Asthmatic Agents; D000069444:Omalizumab